MATERIAL SAFETY DATA SHEET
SECTION 1 - CHEMICAL PRODUCT & COMPANY IDENTIFICATION
Pfizer Consumer Healthcare (973) 385-2000
Emergency telephone
Pfizer Inc 24 hours
Hours of operation
201 Tabor Road
Morris Plains, New Jersey 07950
Product name Neosporin Ointment
Antibiotic agent
Therapeutic use
Colorless gel
Description
SECTION 2 - COMPOSITION/INFORMATION ON INGREDIENTS
Ingredient CAS Number Amount
Polymyxin B sulfate* 1405-20-5 0.05%
Bacitracin Zinc* 1405-89-6 0.8%
Neomycin sulfate* 1405-10-3 0.5%
White petrolatum* 8009-03-8 Proprietary
Cottonseed Oil 8001-29-4 Proprietary
Olive Oil 8001-25-0 Proprietary
Vitamin E acetate* 7695-91-2 Proprietary
Cocoa Butter 8002-31-1 Proprietary
Sodium Pyruvate 113-24-6 Proprietary
*Hazardous
Note: Ingredient(s) indicated as hazardous have been assessed under standards
for workplace safety.
SECTION 3 - HAZARDS IDENTIFICATION
Not applicable
Signal word
Not applicable
Statements of hazard
No data available.
Eye effects
Not expected to cause skin irritation.
Skin effects
No data available.
Inhalation effects
No data available.
Ingestion effects
For a more detailed discussion of potential health hazards and toxicity see
Additional data
Section 11.
WL035 - Neosporin Ointment Pfizer Inc.
Revision date: 04/17/00, Version: 1.0.0 Page 1 of 5
SECTION 3 - HAZARDS IDENTIFICATION ... continued
This document has been prepared in accordance with standards for
NOTE:
workplace safety, which require the inclusion of all known hazards of the
product or its ingredients regardless of the potential risk. The
precautionary statements and warnings included may not apply in all
cases. Your needs may vary depending upon the potential for exposure in
your workplace.
SECTION 4 - FIRST AID MEASURES
Immediately flush eyes with water for at least 15 minutes until no evidence
Eyes
of product remains. If irritation occurs or persists, get medical attention.
Wash exposed area with soap and water, remove contaminated clothing
Skin
and obtain medical assistance if irritation occurs.
Inhalation Remove to fresh air. If discomfort persists, get medical attention.
In the event of swallowing this material, seek medical assistance if
Ingestion
symptoms develop. Do not induce vomiting unless directed by medical
personnel. Give water to dilute unless instructed to do otherwise.
SECTION 5 - FIRE FIGHTING MEASURES
Wear approved positive pressure, self-contained breathing apparatus and
Fire fighting instructions
full protective turn out gear.
Use carbon dioxide, dry chemical, or water spray.
Extinguishing media
Not applicable
Flash point
SECTION 6 - ACCIDENTAL RELEASE MEASURES
Review Sections 3, 8 and 12 before proceeding with clean up.
General
Use absorbant material to wipe up spill and place in a sealed container for
Small spill
disposal. Clean spill area thoroughly.
Collect spill with a non-combustible absorbent material and transfer to
Large spill
labeled container for disposal. Clean spill area thoroughly.
SECTION 7 - HANDLING AND STORAGE
General handling Avoid contact with eyes. Avoid contact with skin and clothing. Avoid
breathing vapor or mist.
Keep in tightly closed containers away from heat and light.
Storage conditions
WL035 - Neosporin Ointment Pfizer Inc.
Revision date: 04/17/00, Version: 1.0.0 Page 2 of 5
SECTION 7 - HANDLING AND STORAGE ... continued
No data available
Temperature range
for storage
SECTION 8 - EXPOSURE CONTROLS/PERSONAL PROTECTION
Exposure limits
Compound Issuer Type OEL
White petrolatum ACGIH STEL (15 min) 10 mg/m鲁 (Oil Mist, mineral)
ACGIH TWA-8 HR 5 mg/m鲁 (Oil Mist, mineral)
OSHA TWA-8 HR 5 mg/m鲁 (Oil Mist, mineral)
Vitamin E Acetate Roche TWA-8 Hr 10 mg/m鲁
Good general ventilation should be sufficient to control airborne levels.
Ventilation
Glasses or goggles are recommended if eye contact is possible.
Eye protection
Wear protective clothing when working with large quantities.
Skin protection
Wear gloves when working with large quantities.
Hand protection
Respirators are not required for normal use of this material.
Respiratory protection
SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES
Gel
Physical form
Off-white
Color
Mixture
Molecular weight
Mixture
Molecular formula
No data available
pH
Slightly soluble
Water solubility
SECTION 10 - STABILITY AND REACTIVITY
Stable
Reactivity
Avoid direct sunlight, conditions that might generate heat, and sources of
Conditions to avoid
ignition.
None known
Incompatibilities
None known
Hazardous
decomposition
products
No data available
Hazardous
polymerization
WL035 - Neosporin Ointment Pfizer Inc.
Revision date: 04/17/00, Version: 1.0.0 Page 3 of 5
SECTION 11 - TOXICOLOGY INFORMATION
Acute toxicity
Compound Type Route Species Dosage
Polymyxin B sulfate LD50 Oral Mouse 750 mg/kg
Not determined for this product.
Eye
Not expected to cause skin irritation.
Skin
Not determined for this product.
Inhalation
Not determined for this product.
Ingestion
Not determined for this product.
Mutagenicity
Not determined for this product.
Subchronic effects
Not determined for this product.
Chronic effects/
carcinogenicity
None of the components of this formulation is listed as a carcinogen by
Carcinogen status
IARC, NTP or OSHA.
Not determined for this product
Reproductive effects
Not determined for this product.
Teratogenicity
SECTION 12 - ECOLOGICAL INFORMATION
The environmental characteristics of this material have not been fully
Environmental overview
evaluated. Releases to the environment should be avoided.
SECTION 13 - DISPOSAL INFORMATION
Observe all local and national regulations when disposing of this material.
Disposal procedure
SECTION 14 - TRANSPORTATION INFORMATION
Not regulated for transport under USDOT, EUADR, IATA, or IMDG
General shipping
regulations.
instructions
SECTION 15 - REGULATORY INFORMATION
Not classified
EU Classification
This product has been classified in accordance with the hazard criteria of
Canadian WHMIS
the CPR and the MSDS contains all of the information required by the
CPR.
WL035 - Neosporin Ointment Pfizer Inc.
Revision date: 04/17/00, Version: 1.0.0 Page 4 of 5
SECTION 16 - OTHER
Disclaimer The information contained in this Material Safety Data Sheet is
believed to be accurate, and while it is provided in good faith, it is
without a warranty of any kind, express or implied.
WL035 - Neosporin Ointment Pfizer Inc.
Revision date: 04/17/00, Version: 1.0.0 Page 5 of 5
|